Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy

Clinical trial NCT06586281 · RECRUITING

Trial details

NCT number: NCT06586281
Sponsor: University of California, San Diego
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2025-06-01
Primary completion: 2027-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.